InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,303.39
(
0.67%
)
US TECH 100
18,334.40
(
1.04%
)
Dow Jones
39,131.06
(
0.17%
)
Brent Oil
81.99
(
0.83%
)
Bitcoin
68,674.59
(
1.10%
)
Post# of 17421
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Zeppo

Send PM Follow Ignore
Followers 16
Posts 1523
Boards Moderated 0
Alias Born 08/09/2011

Zeppo

Re: None

Tuesday, 11/03/2020 10:00:37 AM

Tuesday, November 03, 2020 10:00:37 AM

Post# of 17421
My memory tells me that one of the big reasons the company carried DES forward into higher clinical trials was the head-to-head competition with the Allergan product...already approved. I am interested in viewing company feedback regarding the comparisons between early and present trials to see if a testing glitch might be the culprit. Just like the overall health of the LN patient between Phase 2 and 3, the progression of DES and the stage where it was treated could be significant.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AUPH News
More AUPH News
InvestorsHub NewsWire

Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM

Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM

"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM

North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

Start posting your company's news
Only $200 per official company press release!